Jo Halliday

Founder and CEO

Jo Halliday

Jo Halliday is the Founder and CEO of Talking Medicines Ltd. who are a data tech in Healthcare Company. 

“Our mission is to drive more effective medicines for the healthcare consumer.  We can do that by reinventing the way that marketing teams in Pharmaceutical companies buy consumer insight about how their medicines are consumed in the real world so that they can get closer to the patient. As medicines are increasingly approved on health outcomes this data becomes more valuable. We already cover medicines from over 230 Pharma Companies in the UK, and have two global Pharma Companies as customers.

We gather this data via our proprietary tool called Medsmart® which links the barcode on the packaging of 25,000 prescription & over the counter medicines to trusted and interactive information about the medicine and how to take it, using regulator MHRA as a source.   Medsmart® is now in the 30K-50K App download bracket in the UK.

The ambition is to create a global gold standard in digital real-world data, whilst impacting positively upon the quality of life for users when they use Medsmart® to take control of their medicines.”

Jo Halliday is the Founder and CEO of Talking Medicines Ltd. who are a data tech in Healthcare Company. 

“Our mission is to drive more effective medicines for the healthcare consumer.  We can do that by reinventing the way that marketing teams in Pharmaceutical companies buy consumer insight about how their medicines are consumed in the real world so that they can get closer to the patient. As medicines are increasingly approved on health outcomes this data becomes more valuable. We already cover medicines from over 230 Pharma Companies in the UK, and have two global Pharma Companies as customers.

We gather this data via our proprietary tool called Medsmart® which links the barcode on the packaging of 25,000 prescription & over the counter medicines to trusted and interactive information about the medicine and how to take it, using regulator MHRA as a source.   Medsmart® is now in the 30K-50K App download bracket in the UK.

The ambition is to create a global gold standard in digital real-world data, whilst impacting positively upon the quality of life for users when they use Medsmart® to take control of their medicines.”

Contact Cazenove Capital

To discuss your wealth management requirements, or to find out more about our services and how we can help you, please contact: